Trump’s promise to lower drug prices rattles Swiss pharma stocks
Roche and Novartis lost up to 3% in Zurich on Monday morning.
Keystone / Georgios Kefalas
Select your language
Generated with artificial intelligence.
Listening: Trump’s promise to lower drug prices rattles Swiss pharma stocks
US President Trump wants to make medicines, some of which are exorbitantly expensive, cheaper in the US. This would mean huge losses for drugmakers, including those in Switzerland.
Shares in the pharmaceutical sector have come under heavy pressure worldwide due to concerns about profitability in the US business. US President Donald Trump wants to lower prices for prescription drugs in the USA and is therefore targeting the entire industry.
One of the “most consequential decrees” in US history will be signed on Monday, the Republican announced on his online platform Truth Social. Trump had already held out the prospect of an “earth-shattering” announcement last week. US media had already speculated that it could be about drug prices.
The fact that Trump now wants to get serious has put pharmaceutical shares under heavy pressure internationally: the losses are likely to extend to the US stock markets via Japan and Europe. In European trading on Monday, Sanofi and Novo Nordisk were hit particularly hard with losses of almost 6%. Shares in AstraZeneca and GSK fell by up to 4% in London. Roche and Novartis lost up to 3% in Zurich. Pfizer was down 2.3% in pre-market trading in New York.
More
More
Pharma supply chains
US tariffs pressure Swiss pharma powerhouse
This content was published on
Looming US pharma tariffs could challenge the status quo in pharmaceutical hubs like Switzerland as investment shifts to the US.
Trump wants to force pharmaceutical companies to accept internationally comparable prices. He sees his country at a disadvantage due to high prices. In the US, there is no central government price regulation that applies to all medicines. The pharmaceutical industry plays the most important role in the question of how much a drug costs – government influence is limited. This sometimes leads to enormously high prices – in an international comparison, many drugs in the US are significantly more expensive.
The world wonders why prescription drugs are so much more expensive in the US than in other countries around the world, even though they are produced in the same laboratory by the same company, Trump wrote. He promised that drug prices in the US would fall by 30-80% “almost immediately”.
Translated from German by DeepL/jdp
How we work
We select the most relevant news for an international audience and use automatic translation tools such as DeepL to translate them into English. A journalist then reviews the translation for clarity and accuracy before publication. Providing you with automatically translated news gives us the time to write more in-depth articles. The news stories we select have been written and carefully fact-checked by an external editorial team from news agencies such as Bloomberg or Keystone.
Did you find this explanation helpful? Please fill out the short survey below to help us understand your needs.
External Content
Don’t miss your chance to make a difference! Take our survey and share your thoughts.
Related Stories
Popular Stories
More
International Geneva
A Geneva-based global health foundation came close to ‘collapse’. Where were regulators?
Swiss-EU treaties: signatures handed in for Kompass initiative
This content was published on
The committee behind the Compass Initiative submitted the signatures it had collected to the Federal Chancellery on Friday.
This content was published on
Esther Grether has died aged 89. Considered one of Switzerland’s leading entrepreneurs, the owner of the Basel-based Doetsch Grether Group was also a major shareholder in the Swatch Group and an art collector.
This content was published on
The flag of the Swiss Wrestling Federation has been received at the start of the Swiss Wrestling and Alpine Festival in Mollis, canton Glarus.
Figurine heads in Zurich school not considered discriminatory
This content was published on
The 16 carved figurine heads in the auditorium of the Hirschengraben school building in Zurich are not discriminatory, according to an independent expert report.
Swiss political parties report income of CHF22.4 million for 2024
This content was published on
Ten parties reported income totalling CHF22.4 million for 2024, less than in the 2023 election year. The reports are based on the regulations for transparency in political financing.
FIFA loses multi-million lawsuit against Blatter and Kattner
This content was published on
Former FIFA officials Joseph Blatter and Markus Kattner do not have to pay back their own bonuses or the bonus totalling CHF 23 million paid to another FIFA official to FIFA. This was decided by the Zurich Labour Court.
How cancer cells makes healthy cells work for them
This content was published on
Cancer cells manipulate neighbouring cells for their own purposes: a research team at ETH Zurich has discovered that they can reprogram neighbouring cells in such a way that they help the tumour to grow.
This content was published on
The ban on non-residents entering the swimming pool in Porrentruy, canton Jura, expires on Sunday and would be extended until the end of the season, the mayor said.
Natural disasters: most Swiss back forced resettlement
This content was published on
The authorities should be allowed to order forced relocations if there is a medium-term risk of a natural event, according to 58% of participants in a survey.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.